Biotech Values

[DewDiligence]

>I believe the ASCO policy reflects a requirement imposed on the industry by the FDA. Their rule requires that all data from an ongoing clinical trial must be held confidential by that agency and the company running that trial, But such data is allowed to be presented at recognized scientific assemblies.<

In many cases, the clinical trials on which data release is held for a scientific conference are not ongoing but rather have ended. But the main point is that the FDA-imposed rule you refer to does not exist. There are myriad counter-examples—probably dozens on this board alone—where companies have released clinical data to the public outside the scope of a scientific conference.